Fund Overview of Baroda Bnp Paribas Health And Wellness Fund Direct-growth
-
₹670.4 CrAUM
-
₹9.43NAV
-
0.43%Expense Ratio
-
EquityFund Category
Returns of Baroda Bnp Paribas Health And Wellness Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -1.95% | NA | 6.12% |
Asset Allocation
equities
95.81%debt instruments
3.25%other assets or cash equivalents
0.94%Baroda Bnp Paribas Health And Wellness Fund Direct-growth is one Equity mutual fund offered by Baroda BNP Paribas Mutual Fund. Launched on 27 Jun 2025, the fund aims Long term wealth creation. Investment predominantly in equity & equity related instruments of Pharma and Healthcare Companies. It manages assets worth ₹670.4 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.43%. Fund Manager Manager EducationAbout Baroda Bnp Paribas Health And Wellness Fund Direct-growth
The portfolio allocation consists of 95.81% in equities, 3.25% in debt instruments, 0.94% in other assets or cash equivalents.Managed by Sanjay Chawla, it has delivered a return of 0.00% in the last year, a total return since inception of -2.08%.
Selecting the right best sip plans plays a key part for systematic investing.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.24% | -4.45% | 10.66% | 28.89% | 18.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.31% | -4.64% | 9.76% | 27.80% | 16.99% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | 1.80% | 1.86% | 12.89% | 26.12% | 16.00% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | 1.73% | 1.53% | 11.41% | 24.45% | 14.38% |
More funds from Baroda BNP Paribas Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Baroda Bnp Paribas Health And Wellness Fund Regular-growth
|
₹670 | 1.19% | -0.09% | -3.51% | - | - |
|
Baroda Bnp Paribas Health And Wellness Fund Regular-idcw
|
₹670 | 1.19% | -0.09% | -3.51% | - | - |
|
Baroda Bnp Paribas Health And Wellness Fund Direct-idcw
|
₹670 | 1.32% | 0.34% | -2.65% | - | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹37.61 | 27.80% | 16.99% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹40.73 | 28.89% | 18.02% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.02 | 26.12% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.72 | 24.45% | 14.38% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹149.59 | 26.47% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹17.66 | 25.51% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹17.30 | 24.73% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.00 | 26.64% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Others Cblo | Unspecified | 13.52% | ₹90.63 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.09% | ₹81.07 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.64% | ₹65.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.64% | ₹65.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.25% | ₹57.48 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.25% | ₹57.48 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.99% | ₹54.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.23% | ₹52.11 Cr |
| Others Cblo | Unspecified | 7.88% | ₹48.45 Cr |
| Others Cblo | Unspecified | 7.88% | ₹48.45 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.64% | ₹46.94 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.64% | ₹46.94 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.53% | ₹46.28 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.53% | ₹46.28 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.49% | ₹46.26 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.29% | ₹45.30 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.29% | ₹45.30 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.05% | ₹43.81 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.05% | ₹43.81 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.00% | ₹42.77 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.17% | ₹42.13 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.11% | ₹41.73 Cr |
| Mankind Pharma Ltd. | Healthcare | 7.41% | ₹40.36 Cr |
| Cipla Ltd | Healthcare | 6.51% | ₹39.81 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.90% | ₹39.57 Cr |
| Cipla Ltd | Healthcare | 6.69% | ₹39.29 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.18% | ₹38.41 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.18% | ₹38.41 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.28% | ₹38.37 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.59% | ₹37.49 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.03% | ₹37.05 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.03% | ₹37.05 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.51% | ₹36.93 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.00% | ₹36.68 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.38% | ₹36.03 Cr |
| Cipla Ltd | Healthcare | 5.16% | ₹34.59 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.87% | ₹34.49 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.54% | ₹34.43 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.54% | ₹34.43 Cr |
| Cipla Ltd | Healthcare | 6.32% | ₹34.42 Cr |
| Cipla Ltd | Healthcare | 5.44% | ₹33.45 Cr |
| Cipla Ltd | Healthcare | 5.44% | ₹33.45 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.44% | ₹33.44 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.44% | ₹33.44 Cr |
| Cipla Ltd | Healthcare | 5.38% | ₹33.40 Cr |
| Cipla Ltd | Healthcare | 5.38% | ₹33.40 Cr |
| Lupin Ltd | Healthcare | 5.71% | ₹32.23 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.78% | ₹32.02 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.80% | ₹31.57 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.91% | ₹30.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.91% | ₹30.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.90% | ₹29.95 Cr |
| Abbott India Ltd | Healthcare | 4.82% | ₹29.47 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 5.22% | ₹29.46 Cr |
| Others Cblo | Unspecified | 4.73% | ₹29.39 Cr |
| Others Cblo | Unspecified | 4.73% | ₹29.39 Cr |
| Abbott India Ltd | Healthcare | 4.84% | ₹28.44 Cr |
| Abbott India Ltd | Healthcare | 4.57% | ₹28.42 Cr |
| Abbott India Ltd | Healthcare | 4.57% | ₹28.42 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.80% | ₹28.17 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.99% | ₹28.17 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.73% | ₹27.76 Cr |
| Abbott India Ltd | Healthcare | 4.96% | ₹27.01 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.03% | ₹27.01 Cr |
| Lupin Ltd | Healthcare | 4.94% | ₹26.91 Cr |
| Others Cblo | Unspecified | 4.49% | ₹26.39 Cr |
| Lupin Ltd | Healthcare | 4.49% | ₹26.37 Cr |
| Abbott India Ltd | Healthcare | 4.29% | ₹26.36 Cr |
| Abbott India Ltd | Healthcare | 4.29% | ₹26.36 Cr |
| Abbott India Ltd | Healthcare | 4.60% | ₹26.00 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.59% | ₹25.92 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.24% | ₹25.91 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.73% | ₹25.75 Cr |
| Divi's Laboratories Ltd | Healthcare | 4.35% | ₹25.57 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.08% | ₹25.08 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.08% | ₹25.08 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.26% | ₹25.03 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.56% | ₹24.85 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 4.00% | ₹24.84 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 4.00% | ₹24.84 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.96% | ₹24.18 Cr |
| Gland Pharma Ltd | Healthcare | 3.60% | ₹24.11 Cr |
| Abbott India Ltd | Healthcare | 3.59% | ₹24.08 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 4.00% | ₹23.48 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.15% | ₹23.46 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 3.84% | ₹23.46 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.81% | ₹23.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.81% | ₹23.42 Cr |
| Gland Pharma Ltd | Healthcare | 3.73% | ₹23.15 Cr |
| Gland Pharma Ltd | Healthcare | 3.73% | ₹23.15 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.73% | ₹23.14 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.73% | ₹23.14 Cr |
| Laurus Labs Ltd | Healthcare | 4.09% | ₹23.13 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 4.07% | ₹23.01 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.43% | ₹22.99 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.95% | ₹22.32 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 4.08% | ₹22.23 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.27% | ₹21.89 Cr |
| Others Cblo | Unspecified | 3.53% | ₹21.57 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.94% | ₹21.48 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.47% | ₹21.22 Cr |
| Gland Pharma Ltd | Healthcare | 3.45% | ₹21.12 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.83% | ₹20.88 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.53% | ₹20.72 Cr |
| Gland Pharma Ltd | Healthcare | 3.52% | ₹20.66 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.51% | ₹20.59 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.64% | ₹20.54 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 3.33% | ₹20.49 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 3.33% | ₹20.49 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.05% | ₹20.46 Cr |
| Sbi Life Insurance Company Ltd | Financial | 3.61% | ₹20.37 Cr |
| Biocon Ltd | Healthcare | 3.32% | ₹20.32 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.98% | ₹19.97 Cr |
| Biocon Ltd | Healthcare | 2.98% | ₹19.96 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 3.30% | ₹19.38 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.85% | ₹19.10 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.11% | ₹19.04 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 3.36% | ₹18.98 Cr |
| Biocon Ltd | Healthcare | 3.06% | ₹18.98 Cr |
| Biocon Ltd | Healthcare | 3.06% | ₹18.98 Cr |
| Lupin Ltd | Healthcare | 3.07% | ₹18.74 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.43% | ₹18.70 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.15% | ₹18.48 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 3.39% | ₹18.47 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 2.74% | ₹18.37 Cr |
| Others Cblo | Unspecified | 3.25% | ₹18.37 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.95% | ₹18.33 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.95% | ₹18.33 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.10% | ₹18.20 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.94% | ₹17.97 Cr |
| Gland Pharma Ltd | Healthcare | 2.92% | ₹17.92 Cr |
| Gland Pharma Ltd | Healthcare | 2.92% | ₹17.92 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.91% | ₹17.89 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.91% | ₹17.89 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.66% | ₹17.86 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.87% | ₹17.80 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.87% | ₹17.80 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.90% | ₹17.71 Cr |
| Gland Pharma Ltd | Healthcare | 3.25% | ₹17.71 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.64% | ₹17.69 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.01% | ₹17.68 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.86% | ₹17.58 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.86% | ₹17.58 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.87% | ₹17.57 Cr |
| Gland Pharma Ltd | Healthcare | 3.09% | ₹17.47 Cr |
| Biocon Ltd | Healthcare | 2.83% | ₹17.39 Cr |
| Biocon Ltd | Healthcare | 2.83% | ₹17.39 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.82% | ₹17.35 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.82% | ₹17.35 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.81% | ₹17.26 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.81% | ₹17.26 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.76% | ₹17.14 Cr |
| Icici Prudential Life Insurance Company Ltd | Financial | 2.76% | ₹17.14 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.55% | ₹17.10 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.78% | ₹17.10 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.78% | ₹17.10 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.13% | ₹17.03 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.71% | ₹16.82 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.71% | ₹16.82 Cr |
| Laurus Labs Ltd | Healthcare | 2.48% | ₹16.66 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.95% | ₹16.66 Cr |
| Laurus Labs Ltd | Healthcare | 2.83% | ₹16.62 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.65% | ₹16.47 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.65% | ₹16.47 Cr |
| Natco Pharma Ltd | Healthcare | 2.64% | ₹16.40 Cr |
| Natco Pharma Ltd | Healthcare | 2.64% | ₹16.40 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.92% | ₹15.93 Cr |
| Natco Pharma Ltd | Healthcare | 2.59% | ₹15.91 Cr |
| Natco Pharma Ltd | Healthcare | 2.59% | ₹15.91 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.80% | ₹15.80 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.31% | ₹15.50 Cr |
| Laurus Labs Ltd | Healthcare | 2.83% | ₹15.44 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.82% | ₹15.37 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.50% | ₹15.26 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.43% | ₹15.07 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.43% | ₹15.07 Cr |
| Poly Medicure Ltd | Healthcare | 2.41% | ₹15.00 Cr |
| Poly Medicure Ltd | Healthcare | 2.41% | ₹15.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.43% | ₹14.92 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.43% | ₹14.92 Cr |
| Concord Biotech Ltd. | Healthcare | 2.21% | ₹14.85 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.52% | ₹14.83 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.69% | ₹14.64 Cr |
| Poly Medicure Ltd | Healthcare | 2.38% | ₹14.61 Cr |
| Poly Medicure Ltd | Healthcare | 2.38% | ₹14.61 Cr |
| Poly Medicure Ltd | Healthcare | 2.38% | ₹14.54 Cr |
| Poly Medicure Ltd | Healthcare | 2.17% | ₹14.53 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.59% | ₹14.10 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.48% | ₹14.00 Cr |
| Natco Pharma Ltd | Healthcare | 2.15% | ₹13.16 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.28% | ₹12.86 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.25% | ₹12.72 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.17% | ₹12.71 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.06% | ₹12.59 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.02% | ₹12.54 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.02% | ₹12.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.99% | ₹12.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.99% | ₹12.24 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.24% | ₹12.18 Cr |
| Cipla Ltd | Healthcare | 2.15% | ₹12.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.93% | ₹11.98 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.93% | ₹11.98 Cr |
| Lupin Ltd | Healthcare | 1.90% | ₹11.78 Cr |
| Lupin Ltd | Healthcare | 1.90% | ₹11.78 Cr |
| Others Cblo | Unspecified | 2.11% | ₹11.48 Cr |
| Lupin Ltd | Healthcare | 1.87% | ₹11.47 Cr |
| Lupin Ltd | Healthcare | 1.87% | ₹11.47 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.92% | ₹10.83 Cr |
| Medplus Health Services Ltd | Healthcare | 1.72% | ₹10.51 Cr |
| Medplus Health Services Ltd | Healthcare | 1.79% | ₹10.49 Cr |
| Medplus Health Services Ltd | Healthcare | 1.91% | ₹10.39 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.74% | ₹10.23 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.65% | ₹10.23 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.65% | ₹10.23 Cr |
| Divi's Laboratories Ltd | Healthcare | 1.88% | ₹10.23 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.58% | ₹9.70 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.58% | ₹9.70 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.42% | ₹9.53 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.50% | ₹9.19 Cr |
| Medplus Health Services Ltd | Healthcare | 1.41% | ₹8.77 Cr |
| Medplus Health Services Ltd | Healthcare | 1.41% | ₹8.77 Cr |
| Medplus Health Services Ltd | Healthcare | 1.42% | ₹8.71 Cr |
| Medplus Health Services Ltd | Healthcare | 1.42% | ₹8.71 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.25% | ₹8.38 Cr |
| Concord Biotech Ltd. | Healthcare | 1.34% | ₹8.24 Cr |
| Concord Biotech Ltd. | Healthcare | 1.34% | ₹8.24 Cr |
| Medplus Health Services Ltd | Healthcare | 1.39% | ₹7.86 Cr |
| Laurus Labs Ltd | Healthcare | 1.27% | ₹7.74 Cr |
| Ami Organics Ltd | Healthcare | 1.34% | ₹7.56 Cr |
| Nephrocare Health Services Ltd. | 1.31% | ₹7.42 Cr | |
| Natco Pharma Ltd | Healthcare | 1.07% | ₹7.15 Cr |
| Mankind Pharma Ltd. | Healthcare | 1.19% | ₹6.74 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.07% | ₹6.27 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.01% | ₹6.24 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.01% | ₹6.24 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 1.14% | ₹6.21 Cr |
| Inventurus Knowledge Solutions Ltd. | Industrials | 1.10% | ₹6.19 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.12% | ₹6.08 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.01% | ₹5.68 Cr |
| Poly Medicure Ltd | Healthcare | 0.94% | ₹5.53 Cr |
| Net Receivables | Unspecified | 0.99% | ₹5.53 Cr |
| Metropolis Healthcare Ltd | Healthcare | 0.96% | ₹5.44 Cr |
| Net Receivables | Unspecified | 0.94% | ₹5.38 Cr |
| Metropolis Healthcare Ltd | Healthcare | 0.98% | ₹5.35 Cr |
| Nephrocare Health Services Ltd. | 0.97% | ₹5.28 Cr | |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.71% | ₹4.35 Cr |
| Lupin Ltd | Healthcare | 0.58% | ₹3.86 Cr |
| Metropolis Healthcare Ltd | Healthcare | 0.60% | ₹3.53 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.57% | ₹3.47 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.51% | ₹3.18 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.51% | ₹3.18 Cr |
| Sbi Life Insurance Company Ltd | Financial | 0.55% | ₹3.00 Cr |
| Sanofi India Ltd | Healthcare | 0.40% | ₹2.68 Cr |
| Nephrocare Health Services Ltd. | 0.27% | ₹1.61 Cr | |
| Metropolis Healthcare Ltd | Healthcare | 0.25% | ₹1.53 Cr |
| Net Receivables | Unspecified | 0.15% | ₹0.86 Cr |
| Net Payables | Unspecified | -0.26% | ₹-1.62 Cr |
| Net Payables | Unspecified | -0.26% | ₹-1.62 Cr |
| Net Payables | Unspecified | -0.31% | ₹-1.82 Cr |
| Net Payables | Unspecified | -2.65% | ₹-16.34 Cr |
| Net Payables | Unspecified | -2.65% | ₹-16.34 Cr |
| Net Payables | Unspecified | -6.81% | ₹-45.59 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹40.73 | 28.89% | 18.02% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹37.61 | 27.80% | 16.99% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.02 | 26.12% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.72 | 24.45% | 14.38% | - |
Frequently Asked Questions
Baroda Bnp Paribas Health And Wellness Fund Direct-growth
What is the current AUM of Baroda Bnp Paribas Health And Wellness Fund Direct-growth?
As of Thu Jul 31, 2025, Baroda Bnp Paribas Health And Wellness Fund Direct-growth manages assets worth ₹670.4 crore
What is the portfolio composition of Baroda Bnp Paribas Health And Wellness Fund Direct-growth?
Equity: 95.81%, Debt: 3.25%, Others: 0.94%.
Who manages Baroda Bnp Paribas Health And Wellness Fund Direct-growth?
Baroda Bnp Paribas Health And Wellness Fund Direct-growth is managed by Sanjay Chawla from Baroda BNP Paribas Mutual Fund.
What is the market-cap allocation of Baroda Bnp Paribas Health And Wellness Fund Direct-growth?
Large Cap: 36.23%, Mid Cap: 28.69%, Small Cap: 35.08%.
Which are the top companies Baroda Bnp Paribas Health And Wellness Fund Direct-growth has invested in?
- Others CBLO – 13.52% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.09% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.64% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.64% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.25% of the fund's portfolio
Which are the major sectors Baroda Bnp Paribas Health And Wellness Fund Direct-growth focuses on?
- Healthcare – 823.00% of the fund's portfolio
- Unspecified – 41.26% of the fund's portfolio
- Financial – 30.95% of the fund's portfolio
- – 2.55% of the fund's portfolio
- Industrials – 2.24% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





